the map that leads to those treasures
Along the Atlantic edge of Europe, Portugal has taken a quiet but consequential step in humanity's long effort to understand and steward the ocean's living wealth. A new digital platform, born from years of institutional collaboration under CIIMAR, now unites more than ten thousand records of marine biological materials into a single searchable archive — transforming what were once scattered, siloed collections into a coherent map of possibility. The move reflects a broader recognition that the sea holds not only ecological value but pharmaceutical, agricultural, and industrial potential, and that access to that potential must be organized if it is to be used wisely.
- Decades of marine biological research had been locked inside five separate institutional databases, forcing scientists and companies to navigate a fragmented, time-consuming maze just to find a single organism or sample.
- The launch of the Blue Biobanks Digital Research Platform collapses that maze into one searchable interface, instantly connecting users to living cultures, preserved specimens, and genetic materials spanning bacteria, microalgae, corals, and sponges.
- Industries from pharmaceuticals to cosmetics to environmental remediation now have a direct line to marine resources that could yield novel compounds, bioplastics, or water-cleaning bacterial cultures — discoveries that once depended largely on chance.
- The platform is built on FAIR data principles, ensuring that its holdings remain findable, accessible, interoperable, and reusable as the system grows and new biobanks are added.
- Portugal is positioning itself as a serious player in the blue bioeconomy, betting that organized access to marine biodiversity will accelerate innovation while keeping extraction sustainable.
Portugal has opened a digital gateway to its marine biological heritage. The Blue Biobanks Digital Research Platform, developed under CIIMAR through the Portugal Blue Digital Hub project, consolidates more than 10,000 records from five national biobanks into a single searchable system — ending the era in which a researcher seeking a particular bacterial strain or preserved coral specimen had to contact multiple institutions, each with its own catalog and procedures.
The five integrated collections include culture collections of bacteria, cyanobacteria, and microalgae, as well as preserved specimens such as corals and sponges gathered from diverse marine environments. Together they represent decades of scientific work with applications across biotechnology, pharmaceuticals, cosmetics, aquaculture, bioremediation, and water management. The platform organizes all of this according to FAIR principles, ensuring the data is findable, accessible, interoperable, and reusable.
Principal investigator Ana Paula Mucha frames the biobanks as vaults of underwater treasure and the platform as the map that reveals where those treasures lie. Users can search by organism type or application area, then contact the relevant biobank to request samples, services, or scientific consultation. A cosmetics firm might discover a microalgae strain with novel compounds; an environmental firm might locate a bacterial culture suited to contaminated water; a pharmaceutical researcher might identify genetic material worth pursuing.
The platform is designed to expand, with additional biobanks and broader collections expected in coming years. The larger ambition is to sharpen Portugal's position in the blue bioeconomy — accelerating the translation of marine biodiversity into real-world innovation while keeping use sustainable.
Portugal has opened a new digital gateway to its marine biological wealth. The Blue Biobanks Digital Research Platform, developed under the direction of CIIMAR, consolidates more than 10,000 records from five separate Portuguese biobanks into a single searchable interface—eliminating the need for researchers, companies, and policymakers to navigate multiple independent databases in search of organisms and biological materials.
The platform emerged from the Portugal Blue Digital Hub project with an explicit purpose: to connect the scientific world with industry by making it simpler to identify and access marine resources with practical applications. Those applications span biotechnology, bioremediation, aquaculture, pharmaceuticals, cosmetics, and water management. Before this unified system, the biological collections that represent decades of research and preservation existed in institutional silos. A researcher looking for a particular strain of bacteria or a preserved coral specimen might need to contact five different institutions, each with its own catalog system and access procedures.
The five biobanks now integrated into the platform are the Blue Biotechnology and Ecotoxicology Culture Collection (LEGE-CC), the CIIMAR Microbial Culture Collection (CM2C), the Portuguese Institute for the Sea and Atmosphere algae collection, the Biological Collection Supporting Research at the University of Aveiro, and the DEEP-Biobank. Together, they house living cultures of bacteria, cyanobacteria, and microalgae alongside preserved specimens like corals and sponges collected from diverse marine environments. The platform organizes these holdings according to FAIR principles—a data management standard ensuring that information is findable, accessible, interoperable, and reusable across institutions and sectors.
Ana Paula Mucha, the principal investigator leading the effort at CIIMAR, describes the platform as a bridge between scientific knowledge and commercial innovation. In her framing, the biobanks themselves are vaults holding underwater treasures; the platform is the map that reveals where those treasures lie and how to reach them. Users can search by organism type or by potential application area, then contact the relevant biobank directly to request samples, specialized services, or scientific consultation for product development.
The biological materials held across these collections represent more than historical preservation. They form the raw material for innovation in pharmaceuticals, bioplastics, nutraceuticals, and restoration technologies. A cosmetics company seeking novel compounds might discover a microalgae strain with useful properties. An environmental remediation firm might find a bacterial culture suited to cleaning contaminated water. A pharmaceutical researcher might identify genetic material worth further investigation. Before centralization, such discoveries often depended on chance encounters or exhaustive manual searching.
The platform is designed to grow. CIIMAR and its partners expect to integrate additional biobanks and expand the collections within each existing one over the coming years. The immediate goal is to strengthen Portugal's competitive position in the blue bioeconomy—the economic activity centered on sustainable use of ocean resources. By making scientific infrastructure, data, and industry easier to connect, the platform aims to accelerate the translation of marine biodiversity into tangible innovation while ensuring that extraction and use remain sustainable.
Notable Quotes
This platform was designed to connect blue biobanks with the different sectors of the Blue Economy. Biobanks safeguard underwater treasures, while the platform serves as the map that leads to those treasures.— Ana Paula Mucha, principal investigator at CIIMAR
Through a single access point, the platform makes it easier to discover both living organisms, such as bacteria, cyanobacteria and microalgae, as well as preserved organisms, including corals and sponges, collected from a wide range of marine environments.— Maria Luís Bôto, CIIMAR researcher
The Hearth Conversation Another angle on the story
Why does a single digital platform matter so much here? Couldn't researchers just call the biobanks directly?
They could, but it would be slow and inefficient. Imagine you're a company looking for a microorganism that can break down plastic. You'd have to contact five institutions, explain your need to each one, wait for responses, compare what they have. The platform lets you search once and see everything available across all five at once.
So it's really about speed and visibility.
Exactly. But it's also about discovery. When resources are scattered and hard to access, potential applications go unrealized. A researcher might never know that a particular strain exists because they never thought to contact that particular biobank.
The source mentions FAIR principles. What does that actually mean in practice?
It means the data are standardized so they can talk to each other and be used by different systems. If one biobank catalogs specimens one way and another uses a different system, they can't be searched together. FAIR principles ensure they can be.
And the platform is expected to grow. What does that expansion look like?
More biobanks joining the network, and each existing collection adding new specimens and materials over time. The infrastructure is built to scale. Right now it's five institutions and 10,000 records. In five years it could be ten institutions and 50,000 records.
Who benefits most from this—researchers or industry?
Both, but in different ways. Researchers get access to materials for fundamental science. Industry gets a faster path to finding biological resources for commercial applications. The platform is designed to serve both equally.